Global AI In Clinical Trials Supply, Demand and Key Producers, 2023-2029
The global AI In Clinical Trials market size is expected to reach $ 74 million by 2029, rising at a market growth of 6.5% CAGR during the forecast period (2023-2029).
The AI in Clinical Trials market is experiencing significant growth and is expected to continue to expand in the coming years. AI, or artificial intelligence, is being increasingly utilized in the field of clinical trials to enhance various aspects of the trial process, including patient recruitment, data analysis, and drug development.One major trend in the AI in Clinical Trials market is the use of machine learning algorithms to improve patient recruitment and retention. AI algorithms can analyze large amounts of patient data and identify potential candidates for clinical trials more efficiently and accurately than traditional methods. This can help accelerate the recruitment process and ensure that trials have a diverse and representative patient population.
This report studies the global AI In Clinical Trials demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI In Clinical Trials, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI In Clinical Trials that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI In Clinical Trials total market, 2018-2029, (USD Million)
Global AI In Clinical Trials total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: AI In Clinical Trials total market, key domestic companies and share, (USD Million)
Global AI In Clinical Trials revenue by player and market share 2018-2023, (USD Million)
Global AI In Clinical Trials total market by Type, CAGR, 2018-2029, (USD Million)
Global AI In Clinical Trials total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global AI In Clinical Trials market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Intel, The International Business Machines Corporation(IBM), Koninklijke Philips N.V., ConcertAl, Saama Technologies LLC, Samaa Technologies, Owkin Inc., Numerate and Neuroute, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI In Clinical Trials market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global AI In Clinical Trials Market, By Region:
1. How big is the global AI In Clinical Trials market?
2. What is the demand of the global AI In Clinical Trials market?
3. What is the year over year growth of the global AI In Clinical Trials market?
4. What is the total value of the global AI In Clinical Trials market?
5. Who are the major players in the global AI In Clinical Trials market?
The AI in Clinical Trials market is experiencing significant growth and is expected to continue to expand in the coming years. AI, or artificial intelligence, is being increasingly utilized in the field of clinical trials to enhance various aspects of the trial process, including patient recruitment, data analysis, and drug development.One major trend in the AI in Clinical Trials market is the use of machine learning algorithms to improve patient recruitment and retention. AI algorithms can analyze large amounts of patient data and identify potential candidates for clinical trials more efficiently and accurately than traditional methods. This can help accelerate the recruitment process and ensure that trials have a diverse and representative patient population.
This report studies the global AI In Clinical Trials demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI In Clinical Trials, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI In Clinical Trials that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI In Clinical Trials total market, 2018-2029, (USD Million)
Global AI In Clinical Trials total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: AI In Clinical Trials total market, key domestic companies and share, (USD Million)
Global AI In Clinical Trials revenue by player and market share 2018-2023, (USD Million)
Global AI In Clinical Trials total market by Type, CAGR, 2018-2029, (USD Million)
Global AI In Clinical Trials total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global AI In Clinical Trials market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Intel, The International Business Machines Corporation(IBM), Koninklijke Philips N.V., ConcertAl, Saama Technologies LLC, Samaa Technologies, Owkin Inc., Numerate and Neuroute, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI In Clinical Trials market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global AI In Clinical Trials Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Software
- Service
- Pharmaceutical and Biotechnology Companies
- Contract Research Organization
- Other
- Intel
- The International Business Machines Corporation(IBM)
- Koninklijke Philips N.V.
- ConcertAl
- Saama Technologies LLC
- Samaa Technologies
- Owkin Inc.
- Numerate
- Neuroute
- AiCure
- Ardigen
- Unlearn Al
- PathAl
- Exscentia
- Aitia Infotech Pvt Ltd.
- Euretos
- VeriSIM Life
- Envisagenics
- NURITAs
- BioSymetrics
- BioAge Labs lInc
1. How big is the global AI In Clinical Trials market?
2. What is the demand of the global AI In Clinical Trials market?
3. What is the year over year growth of the global AI In Clinical Trials market?
4. What is the total value of the global AI In Clinical Trials market?
5. Who are the major players in the global AI In Clinical Trials market?
1 SUPPLY SUMMARY
1.1 AI In Clinical Trials Introduction
1.2 World AI In Clinical Trials Market Size & Forecast (2018 & 2022 & 2029)
1.3 World AI In Clinical Trials Total Market by Region (by Headquarter Location)
1.3.1 World AI In Clinical Trials Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States AI In Clinical Trials Market Size (2018-2029)
1.3.3 China AI In Clinical Trials Market Size (2018-2029)
1.3.4 Europe AI In Clinical Trials Market Size (2018-2029)
1.3.5 Japan AI In Clinical Trials Market Size (2018-2029)
1.3.6 South Korea AI In Clinical Trials Market Size (2018-2029)
1.3.7 ASEAN AI In Clinical Trials Market Size (2018-2029)
1.3.8 India AI In Clinical Trials Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI In Clinical Trials Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI In Clinical Trials Major Market Trends
2 DEMAND SUMMARY
2.1 World AI In Clinical Trials Consumption Value (2018-2029)
2.2 World AI In Clinical Trials Consumption Value by Region
2.2.1 World AI In Clinical Trials Consumption Value by Region (2018-2023)
2.2.2 World AI In Clinical Trials Consumption Value Forecast by Region (2024-2029)
2.3 United States AI In Clinical Trials Consumption Value (2018-2029)
2.4 China AI In Clinical Trials Consumption Value (2018-2029)
2.5 Europe AI In Clinical Trials Consumption Value (2018-2029)
2.6 Japan AI In Clinical Trials Consumption Value (2018-2029)
2.7 South Korea AI In Clinical Trials Consumption Value (2018-2029)
2.8 ASEAN AI In Clinical Trials Consumption Value (2018-2029)
2.9 India AI In Clinical Trials Consumption Value (2018-2029)
3 WORLD AI IN CLINICAL TRIALS COMPANIES COMPETITIVE ANALYSIS
3.1 World AI In Clinical Trials Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI In Clinical Trials Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI In Clinical Trials in 2022
3.2.3 Global Concentration Ratios (CR8) for AI In Clinical Trials in 2022
3.3 AI In Clinical Trials Company Evaluation Quadrant
3.4 AI In Clinical Trials Market: Overall Company Footprint Analysis
3.4.1 AI In Clinical Trials Market: Region Footprint
3.4.2 AI In Clinical Trials Market: Company Product Type Footprint
3.4.3 AI In Clinical Trials Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI In Clinical Trials Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI In Clinical Trials Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: AI In Clinical Trials Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: AI In Clinical Trials Consumption Value Comparison
4.2.1 United States VS China: AI In Clinical Trials Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: AI In Clinical Trials Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based AI In Clinical Trials Companies and Market Share, 2018-2023
4.3.1 United States Based AI In Clinical Trials Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI In Clinical Trials Revenue, (2018-2023)
4.4 China Based Companies AI In Clinical Trials Revenue and Market Share, 2018-2023
4.4.1 China Based AI In Clinical Trials Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI In Clinical Trials Revenue, (2018-2023)
4.5 Rest of World Based AI In Clinical Trials Companies and Market Share, 2018-2023
4.5.1 Rest of World Based AI In Clinical Trials Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies AI In Clinical Trials Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World AI In Clinical Trials Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Software
5.2.2 Service
5.3 Market Segment by Type
5.3.1 World AI In Clinical Trials Market Size by Type (2018-2023)
5.3.2 World AI In Clinical Trials Market Size by Type (2024-2029)
5.3.3 World AI In Clinical Trials Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World AI In Clinical Trials Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical and Biotechnology Companies
6.2.2 Contract Research Organization
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World AI In Clinical Trials Market Size by Application (2018-2023)
6.3.2 World AI In Clinical Trials Market Size by Application (2024-2029)
6.3.3 World AI In Clinical Trials Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Intel
7.1.1 Intel Details
7.1.2 Intel Major Business
7.1.3 Intel AI In Clinical Trials Product and Services
7.1.4 Intel AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Intel Recent Developments/Updates
7.1.6 Intel Competitive Strengths & Weaknesses
7.2 The International Business Machines Corporation(IBM)
7.2.1 The International Business Machines Corporation(IBM) Details
7.2.2 The International Business Machines Corporation(IBM) Major Business
7.2.3 The International Business Machines Corporation(IBM) AI In Clinical Trials Product and Services
7.2.4 The International Business Machines Corporation(IBM) AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 The International Business Machines Corporation(IBM) Recent Developments/Updates
7.2.6 The International Business Machines Corporation(IBM) Competitive Strengths & Weaknesses
7.3 Koninklijke Philips N.V.
7.3.1 Koninklijke Philips N.V. Details
7.3.2 Koninklijke Philips N.V. Major Business
7.3.3 Koninklijke Philips N.V. AI In Clinical Trials Product and Services
7.3.4 Koninklijke Philips N.V. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Koninklijke Philips N.V. Recent Developments/Updates
7.3.6 Koninklijke Philips N.V. Competitive Strengths & Weaknesses
7.4 ConcertAl
7.4.1 ConcertAl Details
7.4.2 ConcertAl Major Business
7.4.3 ConcertAl AI In Clinical Trials Product and Services
7.4.4 ConcertAl AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 ConcertAl Recent Developments/Updates
7.4.6 ConcertAl Competitive Strengths & Weaknesses
7.5 Saama Technologies LLC
7.5.1 Saama Technologies LLC Details
7.5.2 Saama Technologies LLC Major Business
7.5.3 Saama Technologies LLC AI In Clinical Trials Product and Services
7.5.4 Saama Technologies LLC AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Saama Technologies LLC Recent Developments/Updates
7.5.6 Saama Technologies LLC Competitive Strengths & Weaknesses
7.6 Samaa Technologies
7.6.1 Samaa Technologies Details
7.6.2 Samaa Technologies Major Business
7.6.3 Samaa Technologies AI In Clinical Trials Product and Services
7.6.4 Samaa Technologies AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Samaa Technologies Recent Developments/Updates
7.6.6 Samaa Technologies Competitive Strengths & Weaknesses
7.7 Owkin Inc.
7.7.1 Owkin Inc. Details
7.7.2 Owkin Inc. Major Business
7.7.3 Owkin Inc. AI In Clinical Trials Product and Services
7.7.4 Owkin Inc. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Owkin Inc. Recent Developments/Updates
7.7.6 Owkin Inc. Competitive Strengths & Weaknesses
7.8 Numerate
7.8.1 Numerate Details
7.8.2 Numerate Major Business
7.8.3 Numerate AI In Clinical Trials Product and Services
7.8.4 Numerate AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Numerate Recent Developments/Updates
7.8.6 Numerate Competitive Strengths & Weaknesses
7.9 Neuroute
7.9.1 Neuroute Details
7.9.2 Neuroute Major Business
7.9.3 Neuroute AI In Clinical Trials Product and Services
7.9.4 Neuroute AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Neuroute Recent Developments/Updates
7.9.6 Neuroute Competitive Strengths & Weaknesses
7.10 AiCure
7.10.1 AiCure Details
7.10.2 AiCure Major Business
7.10.3 AiCure AI In Clinical Trials Product and Services
7.10.4 AiCure AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 AiCure Recent Developments/Updates
7.10.6 AiCure Competitive Strengths & Weaknesses
7.11 Ardigen
7.11.1 Ardigen Details
7.11.2 Ardigen Major Business
7.11.3 Ardigen AI In Clinical Trials Product and Services
7.11.4 Ardigen AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Ardigen Recent Developments/Updates
7.11.6 Ardigen Competitive Strengths & Weaknesses
7.12 Unlearn Al
7.12.1 Unlearn Al Details
7.12.2 Unlearn Al Major Business
7.12.3 Unlearn Al AI In Clinical Trials Product and Services
7.12.4 Unlearn Al AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Unlearn Al Recent Developments/Updates
7.12.6 Unlearn Al Competitive Strengths & Weaknesses
7.13 PathAl
7.13.1 PathAl Details
7.13.2 PathAl Major Business
7.13.3 PathAl AI In Clinical Trials Product and Services
7.13.4 PathAl AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 PathAl Recent Developments/Updates
7.13.6 PathAl Competitive Strengths & Weaknesses
7.14 Exscentia
7.14.1 Exscentia Details
7.14.2 Exscentia Major Business
7.14.3 Exscentia AI In Clinical Trials Product and Services
7.14.4 Exscentia AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Exscentia Recent Developments/Updates
7.14.6 Exscentia Competitive Strengths & Weaknesses
7.15 Aitia Infotech Pvt Ltd.
7.15.1 Aitia Infotech Pvt Ltd. Details
7.15.2 Aitia Infotech Pvt Ltd. Major Business
7.15.3 Aitia Infotech Pvt Ltd. AI In Clinical Trials Product and Services
7.15.4 Aitia Infotech Pvt Ltd. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Aitia Infotech Pvt Ltd. Recent Developments/Updates
7.15.6 Aitia Infotech Pvt Ltd. Competitive Strengths & Weaknesses
7.16 Euretos
7.16.1 Euretos Details
7.16.2 Euretos Major Business
7.16.3 Euretos AI In Clinical Trials Product and Services
7.16.4 Euretos AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Euretos Recent Developments/Updates
7.16.6 Euretos Competitive Strengths & Weaknesses
7.17 VeriSIM Life
7.17.1 VeriSIM Life Details
7.17.2 VeriSIM Life Major Business
7.17.3 VeriSIM Life AI In Clinical Trials Product and Services
7.17.4 VeriSIM Life AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 VeriSIM Life Recent Developments/Updates
7.17.6 VeriSIM Life Competitive Strengths & Weaknesses
7.18 Envisagenics
7.18.1 Envisagenics Details
7.18.2 Envisagenics Major Business
7.18.3 Envisagenics AI In Clinical Trials Product and Services
7.18.4 Envisagenics AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Envisagenics Recent Developments/Updates
7.18.6 Envisagenics Competitive Strengths & Weaknesses
7.19 NURITAs
7.19.1 NURITAs Details
7.19.2 NURITAs Major Business
7.19.3 NURITAs AI In Clinical Trials Product and Services
7.19.4 NURITAs AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 NURITAs Recent Developments/Updates
7.19.6 NURITAs Competitive Strengths & Weaknesses
7.20 BioSymetrics
7.20.1 BioSymetrics Details
7.20.2 BioSymetrics Major Business
7.20.3 BioSymetrics AI In Clinical Trials Product and Services
7.20.4 BioSymetrics AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 BioSymetrics Recent Developments/Updates
7.20.6 BioSymetrics Competitive Strengths & Weaknesses
7.21 BioAge Labs lInc
7.21.1 BioAge Labs lInc Details
7.21.2 BioAge Labs lInc Major Business
7.21.3 BioAge Labs lInc AI In Clinical Trials Product and Services
7.21.4 BioAge Labs lInc AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 BioAge Labs lInc Recent Developments/Updates
7.21.6 BioAge Labs lInc Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 AI In Clinical Trials Industry Chain
8.2 AI In Clinical Trials Upstream Analysis
8.3 AI In Clinical Trials Midstream Analysis
8.4 AI In Clinical Trials Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 AI In Clinical Trials Introduction
1.2 World AI In Clinical Trials Market Size & Forecast (2018 & 2022 & 2029)
1.3 World AI In Clinical Trials Total Market by Region (by Headquarter Location)
1.3.1 World AI In Clinical Trials Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States AI In Clinical Trials Market Size (2018-2029)
1.3.3 China AI In Clinical Trials Market Size (2018-2029)
1.3.4 Europe AI In Clinical Trials Market Size (2018-2029)
1.3.5 Japan AI In Clinical Trials Market Size (2018-2029)
1.3.6 South Korea AI In Clinical Trials Market Size (2018-2029)
1.3.7 ASEAN AI In Clinical Trials Market Size (2018-2029)
1.3.8 India AI In Clinical Trials Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI In Clinical Trials Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI In Clinical Trials Major Market Trends
2 DEMAND SUMMARY
2.1 World AI In Clinical Trials Consumption Value (2018-2029)
2.2 World AI In Clinical Trials Consumption Value by Region
2.2.1 World AI In Clinical Trials Consumption Value by Region (2018-2023)
2.2.2 World AI In Clinical Trials Consumption Value Forecast by Region (2024-2029)
2.3 United States AI In Clinical Trials Consumption Value (2018-2029)
2.4 China AI In Clinical Trials Consumption Value (2018-2029)
2.5 Europe AI In Clinical Trials Consumption Value (2018-2029)
2.6 Japan AI In Clinical Trials Consumption Value (2018-2029)
2.7 South Korea AI In Clinical Trials Consumption Value (2018-2029)
2.8 ASEAN AI In Clinical Trials Consumption Value (2018-2029)
2.9 India AI In Clinical Trials Consumption Value (2018-2029)
3 WORLD AI IN CLINICAL TRIALS COMPANIES COMPETITIVE ANALYSIS
3.1 World AI In Clinical Trials Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI In Clinical Trials Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI In Clinical Trials in 2022
3.2.3 Global Concentration Ratios (CR8) for AI In Clinical Trials in 2022
3.3 AI In Clinical Trials Company Evaluation Quadrant
3.4 AI In Clinical Trials Market: Overall Company Footprint Analysis
3.4.1 AI In Clinical Trials Market: Region Footprint
3.4.2 AI In Clinical Trials Market: Company Product Type Footprint
3.4.3 AI In Clinical Trials Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI In Clinical Trials Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI In Clinical Trials Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: AI In Clinical Trials Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: AI In Clinical Trials Consumption Value Comparison
4.2.1 United States VS China: AI In Clinical Trials Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: AI In Clinical Trials Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based AI In Clinical Trials Companies and Market Share, 2018-2023
4.3.1 United States Based AI In Clinical Trials Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI In Clinical Trials Revenue, (2018-2023)
4.4 China Based Companies AI In Clinical Trials Revenue and Market Share, 2018-2023
4.4.1 China Based AI In Clinical Trials Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI In Clinical Trials Revenue, (2018-2023)
4.5 Rest of World Based AI In Clinical Trials Companies and Market Share, 2018-2023
4.5.1 Rest of World Based AI In Clinical Trials Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies AI In Clinical Trials Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World AI In Clinical Trials Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Software
5.2.2 Service
5.3 Market Segment by Type
5.3.1 World AI In Clinical Trials Market Size by Type (2018-2023)
5.3.2 World AI In Clinical Trials Market Size by Type (2024-2029)
5.3.3 World AI In Clinical Trials Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World AI In Clinical Trials Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical and Biotechnology Companies
6.2.2 Contract Research Organization
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World AI In Clinical Trials Market Size by Application (2018-2023)
6.3.2 World AI In Clinical Trials Market Size by Application (2024-2029)
6.3.3 World AI In Clinical Trials Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Intel
7.1.1 Intel Details
7.1.2 Intel Major Business
7.1.3 Intel AI In Clinical Trials Product and Services
7.1.4 Intel AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Intel Recent Developments/Updates
7.1.6 Intel Competitive Strengths & Weaknesses
7.2 The International Business Machines Corporation(IBM)
7.2.1 The International Business Machines Corporation(IBM) Details
7.2.2 The International Business Machines Corporation(IBM) Major Business
7.2.3 The International Business Machines Corporation(IBM) AI In Clinical Trials Product and Services
7.2.4 The International Business Machines Corporation(IBM) AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 The International Business Machines Corporation(IBM) Recent Developments/Updates
7.2.6 The International Business Machines Corporation(IBM) Competitive Strengths & Weaknesses
7.3 Koninklijke Philips N.V.
7.3.1 Koninklijke Philips N.V. Details
7.3.2 Koninklijke Philips N.V. Major Business
7.3.3 Koninklijke Philips N.V. AI In Clinical Trials Product and Services
7.3.4 Koninklijke Philips N.V. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Koninklijke Philips N.V. Recent Developments/Updates
7.3.6 Koninklijke Philips N.V. Competitive Strengths & Weaknesses
7.4 ConcertAl
7.4.1 ConcertAl Details
7.4.2 ConcertAl Major Business
7.4.3 ConcertAl AI In Clinical Trials Product and Services
7.4.4 ConcertAl AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 ConcertAl Recent Developments/Updates
7.4.6 ConcertAl Competitive Strengths & Weaknesses
7.5 Saama Technologies LLC
7.5.1 Saama Technologies LLC Details
7.5.2 Saama Technologies LLC Major Business
7.5.3 Saama Technologies LLC AI In Clinical Trials Product and Services
7.5.4 Saama Technologies LLC AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Saama Technologies LLC Recent Developments/Updates
7.5.6 Saama Technologies LLC Competitive Strengths & Weaknesses
7.6 Samaa Technologies
7.6.1 Samaa Technologies Details
7.6.2 Samaa Technologies Major Business
7.6.3 Samaa Technologies AI In Clinical Trials Product and Services
7.6.4 Samaa Technologies AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Samaa Technologies Recent Developments/Updates
7.6.6 Samaa Technologies Competitive Strengths & Weaknesses
7.7 Owkin Inc.
7.7.1 Owkin Inc. Details
7.7.2 Owkin Inc. Major Business
7.7.3 Owkin Inc. AI In Clinical Trials Product and Services
7.7.4 Owkin Inc. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Owkin Inc. Recent Developments/Updates
7.7.6 Owkin Inc. Competitive Strengths & Weaknesses
7.8 Numerate
7.8.1 Numerate Details
7.8.2 Numerate Major Business
7.8.3 Numerate AI In Clinical Trials Product and Services
7.8.4 Numerate AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Numerate Recent Developments/Updates
7.8.6 Numerate Competitive Strengths & Weaknesses
7.9 Neuroute
7.9.1 Neuroute Details
7.9.2 Neuroute Major Business
7.9.3 Neuroute AI In Clinical Trials Product and Services
7.9.4 Neuroute AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Neuroute Recent Developments/Updates
7.9.6 Neuroute Competitive Strengths & Weaknesses
7.10 AiCure
7.10.1 AiCure Details
7.10.2 AiCure Major Business
7.10.3 AiCure AI In Clinical Trials Product and Services
7.10.4 AiCure AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 AiCure Recent Developments/Updates
7.10.6 AiCure Competitive Strengths & Weaknesses
7.11 Ardigen
7.11.1 Ardigen Details
7.11.2 Ardigen Major Business
7.11.3 Ardigen AI In Clinical Trials Product and Services
7.11.4 Ardigen AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Ardigen Recent Developments/Updates
7.11.6 Ardigen Competitive Strengths & Weaknesses
7.12 Unlearn Al
7.12.1 Unlearn Al Details
7.12.2 Unlearn Al Major Business
7.12.3 Unlearn Al AI In Clinical Trials Product and Services
7.12.4 Unlearn Al AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Unlearn Al Recent Developments/Updates
7.12.6 Unlearn Al Competitive Strengths & Weaknesses
7.13 PathAl
7.13.1 PathAl Details
7.13.2 PathAl Major Business
7.13.3 PathAl AI In Clinical Trials Product and Services
7.13.4 PathAl AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 PathAl Recent Developments/Updates
7.13.6 PathAl Competitive Strengths & Weaknesses
7.14 Exscentia
7.14.1 Exscentia Details
7.14.2 Exscentia Major Business
7.14.3 Exscentia AI In Clinical Trials Product and Services
7.14.4 Exscentia AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Exscentia Recent Developments/Updates
7.14.6 Exscentia Competitive Strengths & Weaknesses
7.15 Aitia Infotech Pvt Ltd.
7.15.1 Aitia Infotech Pvt Ltd. Details
7.15.2 Aitia Infotech Pvt Ltd. Major Business
7.15.3 Aitia Infotech Pvt Ltd. AI In Clinical Trials Product and Services
7.15.4 Aitia Infotech Pvt Ltd. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Aitia Infotech Pvt Ltd. Recent Developments/Updates
7.15.6 Aitia Infotech Pvt Ltd. Competitive Strengths & Weaknesses
7.16 Euretos
7.16.1 Euretos Details
7.16.2 Euretos Major Business
7.16.3 Euretos AI In Clinical Trials Product and Services
7.16.4 Euretos AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Euretos Recent Developments/Updates
7.16.6 Euretos Competitive Strengths & Weaknesses
7.17 VeriSIM Life
7.17.1 VeriSIM Life Details
7.17.2 VeriSIM Life Major Business
7.17.3 VeriSIM Life AI In Clinical Trials Product and Services
7.17.4 VeriSIM Life AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 VeriSIM Life Recent Developments/Updates
7.17.6 VeriSIM Life Competitive Strengths & Weaknesses
7.18 Envisagenics
7.18.1 Envisagenics Details
7.18.2 Envisagenics Major Business
7.18.3 Envisagenics AI In Clinical Trials Product and Services
7.18.4 Envisagenics AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Envisagenics Recent Developments/Updates
7.18.6 Envisagenics Competitive Strengths & Weaknesses
7.19 NURITAs
7.19.1 NURITAs Details
7.19.2 NURITAs Major Business
7.19.3 NURITAs AI In Clinical Trials Product and Services
7.19.4 NURITAs AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 NURITAs Recent Developments/Updates
7.19.6 NURITAs Competitive Strengths & Weaknesses
7.20 BioSymetrics
7.20.1 BioSymetrics Details
7.20.2 BioSymetrics Major Business
7.20.3 BioSymetrics AI In Clinical Trials Product and Services
7.20.4 BioSymetrics AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 BioSymetrics Recent Developments/Updates
7.20.6 BioSymetrics Competitive Strengths & Weaknesses
7.21 BioAge Labs lInc
7.21.1 BioAge Labs lInc Details
7.21.2 BioAge Labs lInc Major Business
7.21.3 BioAge Labs lInc AI In Clinical Trials Product and Services
7.21.4 BioAge Labs lInc AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 BioAge Labs lInc Recent Developments/Updates
7.21.6 BioAge Labs lInc Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 AI In Clinical Trials Industry Chain
8.2 AI In Clinical Trials Upstream Analysis
8.3 AI In Clinical Trials Midstream Analysis
8.4 AI In Clinical Trials Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World AI In Clinical Trials Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World AI In Clinical Trials Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World AI In Clinical Trials Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World AI In Clinical Trials Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World AI In Clinical Trials Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI In Clinical Trials Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World AI In Clinical Trials Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World AI In Clinical Trials Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World AI In Clinical Trials Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key AI In Clinical Trials Players in 2022
Table 12. World AI In Clinical Trials Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global AI In Clinical Trials Company Evaluation Quadrant
Table 14. Head Office of Key AI In Clinical Trials Player
Table 15. AI In Clinical Trials Market: Company Product Type Footprint
Table 16. AI In Clinical Trials Market: Company Product Application Footprint
Table 17. AI In Clinical Trials Mergers & Acquisitions Activity
Table 18. United States VS China AI In Clinical Trials Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China AI In Clinical Trials Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based AI In Clinical Trials Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI In Clinical Trials Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies AI In Clinical Trials Revenue Market Share (2018-2023)
Table 23. China Based AI In Clinical Trials Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI In Clinical Trials Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies AI In Clinical Trials Revenue Market Share (2018-2023)
Table 26. Rest of World Based AI In Clinical Trials Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies AI In Clinical Trials Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies AI In Clinical Trials Revenue Market Share (2018-2023)
Table 29. World AI In Clinical Trials Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World AI In Clinical Trials Market Size by Type (2018-2023) & (USD Million)
Table 31. World AI In Clinical Trials Market Size by Type (2024-2029) & (USD Million)
Table 32. World AI In Clinical Trials Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World AI In Clinical Trials Market Size by Application (2018-2023) & (USD Million)
Table 34. World AI In Clinical Trials Market Size by Application (2024-2029) & (USD Million)
Table 35. Intel Basic Information, Area Served and Competitors
Table 36. Intel Major Business
Table 37. Intel AI In Clinical Trials Product and Services
Table 38. Intel AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Intel Recent Developments/Updates
Table 40. Intel Competitive Strengths & Weaknesses
Table 41. The International Business Machines Corporation(IBM) Basic Information, Area Served and Competitors
Table 42. The International Business Machines Corporation(IBM) Major Business
Table 43. The International Business Machines Corporation(IBM) AI In Clinical Trials Product and Services
Table 44. The International Business Machines Corporation(IBM) AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. The International Business Machines Corporation(IBM) Recent Developments/Updates
Table 46. The International Business Machines Corporation(IBM) Competitive Strengths & Weaknesses
Table 47. Koninklijke Philips N.V. Basic Information, Area Served and Competitors
Table 48. Koninklijke Philips N.V. Major Business
Table 49. Koninklijke Philips N.V. AI In Clinical Trials Product and Services
Table 50. Koninklijke Philips N.V. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Koninklijke Philips N.V. Recent Developments/Updates
Table 52. Koninklijke Philips N.V. Competitive Strengths & Weaknesses
Table 53. ConcertAl Basic Information, Area Served and Competitors
Table 54. ConcertAl Major Business
Table 55. ConcertAl AI In Clinical Trials Product and Services
Table 56. ConcertAl AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. ConcertAl Recent Developments/Updates
Table 58. ConcertAl Competitive Strengths & Weaknesses
Table 59. Saama Technologies LLC Basic Information, Area Served and Competitors
Table 60. Saama Technologies LLC Major Business
Table 61. Saama Technologies LLC AI In Clinical Trials Product and Services
Table 62. Saama Technologies LLC AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Saama Technologies LLC Recent Developments/Updates
Table 64. Saama Technologies LLC Competitive Strengths & Weaknesses
Table 65. Samaa Technologies Basic Information, Area Served and Competitors
Table 66. Samaa Technologies Major Business
Table 67. Samaa Technologies AI In Clinical Trials Product and Services
Table 68. Samaa Technologies AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Samaa Technologies Recent Developments/Updates
Table 70. Samaa Technologies Competitive Strengths & Weaknesses
Table 71. Owkin Inc. Basic Information, Area Served and Competitors
Table 72. Owkin Inc. Major Business
Table 73. Owkin Inc. AI In Clinical Trials Product and Services
Table 74. Owkin Inc. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Owkin Inc. Recent Developments/Updates
Table 76. Owkin Inc. Competitive Strengths & Weaknesses
Table 77. Numerate Basic Information, Area Served and Competitors
Table 78. Numerate Major Business
Table 79. Numerate AI In Clinical Trials Product and Services
Table 80. Numerate AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Numerate Recent Developments/Updates
Table 82. Numerate Competitive Strengths & Weaknesses
Table 83. Neuroute Basic Information, Area Served and Competitors
Table 84. Neuroute Major Business
Table 85. Neuroute AI In Clinical Trials Product and Services
Table 86. Neuroute AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Neuroute Recent Developments/Updates
Table 88. Neuroute Competitive Strengths & Weaknesses
Table 89. AiCure Basic Information, Area Served and Competitors
Table 90. AiCure Major Business
Table 91. AiCure AI In Clinical Trials Product and Services
Table 92. AiCure AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. AiCure Recent Developments/Updates
Table 94. AiCure Competitive Strengths & Weaknesses
Table 95. Ardigen Basic Information, Area Served and Competitors
Table 96. Ardigen Major Business
Table 97. Ardigen AI In Clinical Trials Product and Services
Table 98. Ardigen AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Ardigen Recent Developments/Updates
Table 100. Ardigen Competitive Strengths & Weaknesses
Table 101. Unlearn Al Basic Information, Area Served and Competitors
Table 102. Unlearn Al Major Business
Table 103. Unlearn Al AI In Clinical Trials Product and Services
Table 104. Unlearn Al AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Unlearn Al Recent Developments/Updates
Table 106. Unlearn Al Competitive Strengths & Weaknesses
Table 107. PathAl Basic Information, Area Served and Competitors
Table 108. PathAl Major Business
Table 109. PathAl AI In Clinical Trials Product and Services
Table 110. PathAl AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. PathAl Recent Developments/Updates
Table 112. PathAl Competitive Strengths & Weaknesses
Table 113. Exscentia Basic Information, Area Served and Competitors
Table 114. Exscentia Major Business
Table 115. Exscentia AI In Clinical Trials Product and Services
Table 116. Exscentia AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Exscentia Recent Developments/Updates
Table 118. Exscentia Competitive Strengths & Weaknesses
Table 119. Aitia Infotech Pvt Ltd. Basic Information, Area Served and Competitors
Table 120. Aitia Infotech Pvt Ltd. Major Business
Table 121. Aitia Infotech Pvt Ltd. AI In Clinical Trials Product and Services
Table 122. Aitia Infotech Pvt Ltd. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Aitia Infotech Pvt Ltd. Recent Developments/Updates
Table 124. Aitia Infotech Pvt Ltd. Competitive Strengths & Weaknesses
Table 125. Euretos Basic Information, Area Served and Competitors
Table 126. Euretos Major Business
Table 127. Euretos AI In Clinical Trials Product and Services
Table 128. Euretos AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Euretos Recent Developments/Updates
Table 130. Euretos Competitive Strengths & Weaknesses
Table 131. VeriSIM Life Basic Information, Area Served and Competitors
Table 132. VeriSIM Life Major Business
Table 133. VeriSIM Life AI In Clinical Trials Product and Services
Table 134. VeriSIM Life AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. VeriSIM Life Recent Developments/Updates
Table 136. VeriSIM Life Competitive Strengths & Weaknesses
Table 137. Envisagenics Basic Information, Area Served and Competitors
Table 138. Envisagenics Major Business
Table 139. Envisagenics AI In Clinical Trials Product and Services
Table 140. Envisagenics AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Envisagenics Recent Developments/Updates
Table 142. Envisagenics Competitive Strengths & Weaknesses
Table 143. NURITAs Basic Information, Area Served and Competitors
Table 144. NURITAs Major Business
Table 145. NURITAs AI In Clinical Trials Product and Services
Table 146. NURITAs AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. NURITAs Recent Developments/Updates
Table 148. NURITAs Competitive Strengths & Weaknesses
Table 149. BioSymetrics Basic Information, Area Served and Competitors
Table 150. BioSymetrics Major Business
Table 151. BioSymetrics AI In Clinical Trials Product and Services
Table 152. BioSymetrics AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. BioSymetrics Recent Developments/Updates
Table 154. BioAge Labs lInc Basic Information, Area Served and Competitors
Table 155. BioAge Labs lInc Major Business
Table 156. BioAge Labs lInc AI In Clinical Trials Product and Services
Table 157. BioAge Labs lInc AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 158. Global Key Players of AI In Clinical Trials Upstream (Raw Materials)
Table 159. AI In Clinical Trials Typical Customers
List of Figure
Figure 1. AI In Clinical Trials Picture
Figure 2. World AI In Clinical Trials Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World AI In Clinical Trials Total Market Size (2018-2029) & (USD Million)
Figure 4. World AI In Clinical Trials Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World AI In Clinical Trials Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 13. AI In Clinical Trials Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 16. World AI In Clinical Trials Consumption Value Market Share by Region (2018-2029)
Figure 17. United States AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 18. China AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 23. India AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of AI In Clinical Trials by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI In Clinical Trials Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI In Clinical Trials Markets in 2022
Figure 27. United States VS China: AI In Clinical Trials Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: AI In Clinical Trials Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World AI In Clinical Trials Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World AI In Clinical Trials Market Size Market Share by Type in 2022
Figure 31. Software
Figure 32. Service
Figure 33. World AI In Clinical Trials Market Size Market Share by Type (2018-2029)
Figure 34. World AI In Clinical Trials Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World AI In Clinical Trials Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical and Biotechnology Companies
Figure 37. Contract Research Organization
Figure 38. Other
Figure 39. AI In Clinical Trials Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World AI In Clinical Trials Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World AI In Clinical Trials Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World AI In Clinical Trials Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World AI In Clinical Trials Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World AI In Clinical Trials Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI In Clinical Trials Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World AI In Clinical Trials Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World AI In Clinical Trials Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World AI In Clinical Trials Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key AI In Clinical Trials Players in 2022
Table 12. World AI In Clinical Trials Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global AI In Clinical Trials Company Evaluation Quadrant
Table 14. Head Office of Key AI In Clinical Trials Player
Table 15. AI In Clinical Trials Market: Company Product Type Footprint
Table 16. AI In Clinical Trials Market: Company Product Application Footprint
Table 17. AI In Clinical Trials Mergers & Acquisitions Activity
Table 18. United States VS China AI In Clinical Trials Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China AI In Clinical Trials Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based AI In Clinical Trials Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI In Clinical Trials Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies AI In Clinical Trials Revenue Market Share (2018-2023)
Table 23. China Based AI In Clinical Trials Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI In Clinical Trials Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies AI In Clinical Trials Revenue Market Share (2018-2023)
Table 26. Rest of World Based AI In Clinical Trials Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies AI In Clinical Trials Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies AI In Clinical Trials Revenue Market Share (2018-2023)
Table 29. World AI In Clinical Trials Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World AI In Clinical Trials Market Size by Type (2018-2023) & (USD Million)
Table 31. World AI In Clinical Trials Market Size by Type (2024-2029) & (USD Million)
Table 32. World AI In Clinical Trials Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World AI In Clinical Trials Market Size by Application (2018-2023) & (USD Million)
Table 34. World AI In Clinical Trials Market Size by Application (2024-2029) & (USD Million)
Table 35. Intel Basic Information, Area Served and Competitors
Table 36. Intel Major Business
Table 37. Intel AI In Clinical Trials Product and Services
Table 38. Intel AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Intel Recent Developments/Updates
Table 40. Intel Competitive Strengths & Weaknesses
Table 41. The International Business Machines Corporation(IBM) Basic Information, Area Served and Competitors
Table 42. The International Business Machines Corporation(IBM) Major Business
Table 43. The International Business Machines Corporation(IBM) AI In Clinical Trials Product and Services
Table 44. The International Business Machines Corporation(IBM) AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. The International Business Machines Corporation(IBM) Recent Developments/Updates
Table 46. The International Business Machines Corporation(IBM) Competitive Strengths & Weaknesses
Table 47. Koninklijke Philips N.V. Basic Information, Area Served and Competitors
Table 48. Koninklijke Philips N.V. Major Business
Table 49. Koninklijke Philips N.V. AI In Clinical Trials Product and Services
Table 50. Koninklijke Philips N.V. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Koninklijke Philips N.V. Recent Developments/Updates
Table 52. Koninklijke Philips N.V. Competitive Strengths & Weaknesses
Table 53. ConcertAl Basic Information, Area Served and Competitors
Table 54. ConcertAl Major Business
Table 55. ConcertAl AI In Clinical Trials Product and Services
Table 56. ConcertAl AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. ConcertAl Recent Developments/Updates
Table 58. ConcertAl Competitive Strengths & Weaknesses
Table 59. Saama Technologies LLC Basic Information, Area Served and Competitors
Table 60. Saama Technologies LLC Major Business
Table 61. Saama Technologies LLC AI In Clinical Trials Product and Services
Table 62. Saama Technologies LLC AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Saama Technologies LLC Recent Developments/Updates
Table 64. Saama Technologies LLC Competitive Strengths & Weaknesses
Table 65. Samaa Technologies Basic Information, Area Served and Competitors
Table 66. Samaa Technologies Major Business
Table 67. Samaa Technologies AI In Clinical Trials Product and Services
Table 68. Samaa Technologies AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Samaa Technologies Recent Developments/Updates
Table 70. Samaa Technologies Competitive Strengths & Weaknesses
Table 71. Owkin Inc. Basic Information, Area Served and Competitors
Table 72. Owkin Inc. Major Business
Table 73. Owkin Inc. AI In Clinical Trials Product and Services
Table 74. Owkin Inc. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Owkin Inc. Recent Developments/Updates
Table 76. Owkin Inc. Competitive Strengths & Weaknesses
Table 77. Numerate Basic Information, Area Served and Competitors
Table 78. Numerate Major Business
Table 79. Numerate AI In Clinical Trials Product and Services
Table 80. Numerate AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Numerate Recent Developments/Updates
Table 82. Numerate Competitive Strengths & Weaknesses
Table 83. Neuroute Basic Information, Area Served and Competitors
Table 84. Neuroute Major Business
Table 85. Neuroute AI In Clinical Trials Product and Services
Table 86. Neuroute AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Neuroute Recent Developments/Updates
Table 88. Neuroute Competitive Strengths & Weaknesses
Table 89. AiCure Basic Information, Area Served and Competitors
Table 90. AiCure Major Business
Table 91. AiCure AI In Clinical Trials Product and Services
Table 92. AiCure AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. AiCure Recent Developments/Updates
Table 94. AiCure Competitive Strengths & Weaknesses
Table 95. Ardigen Basic Information, Area Served and Competitors
Table 96. Ardigen Major Business
Table 97. Ardigen AI In Clinical Trials Product and Services
Table 98. Ardigen AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Ardigen Recent Developments/Updates
Table 100. Ardigen Competitive Strengths & Weaknesses
Table 101. Unlearn Al Basic Information, Area Served and Competitors
Table 102. Unlearn Al Major Business
Table 103. Unlearn Al AI In Clinical Trials Product and Services
Table 104. Unlearn Al AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Unlearn Al Recent Developments/Updates
Table 106. Unlearn Al Competitive Strengths & Weaknesses
Table 107. PathAl Basic Information, Area Served and Competitors
Table 108. PathAl Major Business
Table 109. PathAl AI In Clinical Trials Product and Services
Table 110. PathAl AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. PathAl Recent Developments/Updates
Table 112. PathAl Competitive Strengths & Weaknesses
Table 113. Exscentia Basic Information, Area Served and Competitors
Table 114. Exscentia Major Business
Table 115. Exscentia AI In Clinical Trials Product and Services
Table 116. Exscentia AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Exscentia Recent Developments/Updates
Table 118. Exscentia Competitive Strengths & Weaknesses
Table 119. Aitia Infotech Pvt Ltd. Basic Information, Area Served and Competitors
Table 120. Aitia Infotech Pvt Ltd. Major Business
Table 121. Aitia Infotech Pvt Ltd. AI In Clinical Trials Product and Services
Table 122. Aitia Infotech Pvt Ltd. AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Aitia Infotech Pvt Ltd. Recent Developments/Updates
Table 124. Aitia Infotech Pvt Ltd. Competitive Strengths & Weaknesses
Table 125. Euretos Basic Information, Area Served and Competitors
Table 126. Euretos Major Business
Table 127. Euretos AI In Clinical Trials Product and Services
Table 128. Euretos AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Euretos Recent Developments/Updates
Table 130. Euretos Competitive Strengths & Weaknesses
Table 131. VeriSIM Life Basic Information, Area Served and Competitors
Table 132. VeriSIM Life Major Business
Table 133. VeriSIM Life AI In Clinical Trials Product and Services
Table 134. VeriSIM Life AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. VeriSIM Life Recent Developments/Updates
Table 136. VeriSIM Life Competitive Strengths & Weaknesses
Table 137. Envisagenics Basic Information, Area Served and Competitors
Table 138. Envisagenics Major Business
Table 139. Envisagenics AI In Clinical Trials Product and Services
Table 140. Envisagenics AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Envisagenics Recent Developments/Updates
Table 142. Envisagenics Competitive Strengths & Weaknesses
Table 143. NURITAs Basic Information, Area Served and Competitors
Table 144. NURITAs Major Business
Table 145. NURITAs AI In Clinical Trials Product and Services
Table 146. NURITAs AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. NURITAs Recent Developments/Updates
Table 148. NURITAs Competitive Strengths & Weaknesses
Table 149. BioSymetrics Basic Information, Area Served and Competitors
Table 150. BioSymetrics Major Business
Table 151. BioSymetrics AI In Clinical Trials Product and Services
Table 152. BioSymetrics AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. BioSymetrics Recent Developments/Updates
Table 154. BioAge Labs lInc Basic Information, Area Served and Competitors
Table 155. BioAge Labs lInc Major Business
Table 156. BioAge Labs lInc AI In Clinical Trials Product and Services
Table 157. BioAge Labs lInc AI In Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 158. Global Key Players of AI In Clinical Trials Upstream (Raw Materials)
Table 159. AI In Clinical Trials Typical Customers
List of Figure
Figure 1. AI In Clinical Trials Picture
Figure 2. World AI In Clinical Trials Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World AI In Clinical Trials Total Market Size (2018-2029) & (USD Million)
Figure 4. World AI In Clinical Trials Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World AI In Clinical Trials Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company AI In Clinical Trials Revenue (2018-2029) & (USD Million)
Figure 13. AI In Clinical Trials Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 16. World AI In Clinical Trials Consumption Value Market Share by Region (2018-2029)
Figure 17. United States AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 18. China AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 23. India AI In Clinical Trials Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of AI In Clinical Trials by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI In Clinical Trials Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI In Clinical Trials Markets in 2022
Figure 27. United States VS China: AI In Clinical Trials Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: AI In Clinical Trials Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World AI In Clinical Trials Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World AI In Clinical Trials Market Size Market Share by Type in 2022
Figure 31. Software
Figure 32. Service
Figure 33. World AI In Clinical Trials Market Size Market Share by Type (2018-2029)
Figure 34. World AI In Clinical Trials Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World AI In Clinical Trials Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical and Biotechnology Companies
Figure 37. Contract Research Organization
Figure 38. Other
Figure 39. AI In Clinical Trials Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
